Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 163

Total Visits per Month

February 2015 March 2015 April 2015 May 2015 June 2015 July 2015 August 2015
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 4 4 5 2 6 3 3

File Downloads

Views
dce-mri abstract.pdf 13

Top Country Views

Views
United States 58
Canada 16
China 9
Russia 9
United Kingdom 7
France 4
Netherlands 4
Italy 3
South Korea 3
Sweden 2

Top City Views

Views
Miami Beach 22
Toronto 12
Santa Clara 6
Zhengzhou 6
Kansas City 5
Beijing 2
Busto Arsizio 2
Lethbridge 2
Nynäs 2
Seoul 2